Revenue
2022
2023
2024
2025
Tonix Pharmaceuticals Holding Corp. (TNXP)
Price$13.12Cached quote
Net income
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1M | $10.1M | $7.8M | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | $6.5M | $2.3M | $3.0M | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross margin | 49.34% | 23.07% | 38.97% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $44.5M | $40.0M | $86.7M | $81.9M | $68.8M | $36.2M | $18.2M | $17.6M | $13.3M | $28.5M | $35.5M | $18.6M | $4.7M | $2.6M | $1.2M | $584,298 | — | — |
| Operating expenses | $138.8M | $146.8M | $126.1M | $112.1M | — | — | — | — | — | — | $48.2M | $27.7M | $10.9M | $6.7M | $3.4M | $1.9M | — | — |
| Operating income | −$125.7M | −$136.7M | −$118.4M | −$112.1M | −$92.3M | −$50.5M | −$28.8M | −$26.3M | −$21.3M | −$39.0M | −$48.2M | −$27.7M | −$10.9M | −$6.7M | −$3.4M | −$1.9M | — | — |
| Operating margin | −959.05% | −1,354.28% | −1,523.94% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$123.8M | −$133.3M | −$114.1M | −$110.8M | −$92.3M | −$50.5M | −$28.8M | −$26.3M | −$21.2M | −$38.8M | −$48.0M | −$27.6M | −$10.9M | −$6.6M | −$3.4M | −$1.9M | — | — |
| EBITDA margin | −944.37% | −1,320.39% | −1,468.70% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$124.0M | −$130.0M | −$116.7M | −$110.2M | −$92.3M | −$50.5M | −$28.6M | −$26.1M | −$21.1M | −$38.8M | −$48.1M | −$27.6M | −$10.9M | −$9.4M | −$3.5M | −$2.0M | −$221,000 | −$202,000 |
| Net profit margin | −946.22% | −1,288.25% | −1,501.78% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$14.57 | -$176,600.00 | -$678.15 | -$1,980.99 | -$801.90 | -$54.45 | -$1,913.67 | -$25,725.15 | -$31,373.10 | -$152,559.00 | -$283,338.00 | -$274,230.00 | -$333,630.00 | -$552,420.00 | -$320,760.00 | -$7,128,000.00 | — | — |
| Diluted EPSper diluted share | -$14.57 | -$176,600.00 | -$678.15 | -$1,980.99 | -$801.90 | -$54.45 | -$1,913.67 | -$25,725.15 | -$31,373.10 | -$152,559.00 | -$283,338.00 | -$274,230.00 | -$333,630.00 | -$552,420.00 | -$320,760.00 | -$7,128,000.00 | — | — |
Owners
Reported shareholders
8.33%of listed shares
BlackRock, Inc.1.4M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 8.33%1.4M shares |
Point72 Asset Management, L.P. | 6.95%1.17M shares |
MILLENNIUM MANAGEMENT LLC | 5.76%966.93K shares |
AQR CAPITAL MANAGEMENT LLC | 5.26%882.6K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.12%691.9K shares |
Jones Hill Capital LP | 3.72%625.43K shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.35%395.26K shares |
Ishara Investments LP | 2.01%338.25K shares |
STATE STREET CORP | 1.62%271.37K shares |
UBS Group AG | 1.38%231.68K shares |
CITADEL ADVISORS LLC | 1.17%195.86K shares |
ESSEX INVESTMENT MANAGEMENT CO LLC | 0.98%165.14K shares |
Balyasny Asset Management L.P. | 0.79%132.59K shares |
NORTHERN TRUST CORP | 0.72%120.39K shares |
Nuveen, LLC | 0.70%117.45K shares |
VANGUARD FIDUCIARY TRUST CO | 0.61%102.05K shares |
GOLDMAN SACHS GROUP INC | 0.59%98.36K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.58%97.95K shares |
FMR LLC | 0.56%93.55K shares |
IEQ CAPITAL, LLC | 0.55%92.37K shares |
Percentages use 16.79M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 | Taylor Carolyn E.Director | BuyCommon Stock, $0.001 par value | 1.4K | $10.55 | $14.9K | 1.8K |
| Jun 9, 2026Form 4 | LEDERMAN SETHChief Executive Officer | BuyCommon Stock, $0.001 par value | 5.0K | $11.79 | $58.9K | 9.0K |
| Jun 8, 2026Form 4 | Stillwell Richard NewcombDirector | BuyCommon Stock, $0.001 par value | 5.0K | $11.65 | $58.3K | 5.0K |
| Mar 31, 2026Form 4 | LEDERMAN SETHChief Executive Officer | BuyCommon Stock, $0.001 par value · indirect | 5.0K | $12.62 | $63.1K | 20.0K |
| Mar 18, 2026Form 4 | LEDERMAN SETHChief Executive Officer | BuyCommon Stock, $0.001 par value · indirect | 15.0K | $14.89 | $223.3K | 15.0K |